Clinical Trials Logo

Filter by:
NCT ID: NCT03513445 Withdrawn - Clinical trials for Degenerative Disc Disease

Peri-Incisional Drug Injection in Lumbar Spine Surgery

Start date: June 1, 2018
Phase: Phase 3
Study type: Interventional

This is a randomized prospective study that will compare the use of narcotics in a control group of non-injected patients with a treatment arm of patients injected intra-operatively with a ropivacaine, morphine, and epinephrine cocktail. The investigators hypothesize that this treatment will reduce narcotic use in patients during their hospital stay, and possibly decrease the length of their stay in the hospital.The investigators also hope their pain will be decreased as displayed by their multi-daily Clinically Aligned Pain Assessment (CAPA) score.

NCT ID: NCT03511417 Withdrawn - Clinical trials for Hearing Loss, Functional

The Effectiveness of Over the Counter Hearing Products for Middle-Aged Adults

Start date: October 16, 2018
Phase: N/A
Study type: Interventional

The investigators will examine the effectiveness of selected over-the-counter personal sound amplifiers in addressing functional hearing problems in middle-aged listeners with mild hearing loss. Many people are unlikely to pay several thousand dollars for hearing aids but they likely would be more willing to try a possible solution that is less expensive. When faced with counseling these individuals, audiologists are at a loss regarding whether or not to suggest that they try this type of technology, since there is virtually no research available to verify that these devices actually are helpful, particularly for individuals with mild hearing loss. The hypothesis being tested is that personal sound amplifiers can improve functional hearing and decrease cognitive load in complex auditory environments.

NCT ID: NCT03511079 Withdrawn - Breast Cancer Clinical Trials

Music as a Perioperative Therapy in Breast Cancer Patients

Start date: July 10, 2019
Phase: N/A
Study type: Interventional

Music has often been used in hospitals as a therapy but there is a limited amount of research looking at how music actually affects the different molecules in the body, such as cortisol (a marker of stress). There is especially a lack of research in the context of surgery. The hope is that this study will show that music can be used to minimize some of the side effects related to breast surgery and improve the patient experience.

NCT ID: NCT03508804 Withdrawn - Pain Clinical Trials

Lidocaine-Prilocaine Cream in Conjunction With Paracervical Block for Pain With Abortion

Start date: December 2020
Phase: Phase 3
Study type: Interventional

The investigators theorize that the application of a lidocaine-prilocaine cream 5-10 minutes prior to the administration of a paracervical block could decrease pain associated with its administration and pain with abortion overall.

NCT ID: NCT03508648 Withdrawn - Clinical trials for Stress Urinary Incontinence

Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence

Start date: May 28, 2018
Phase: Phase 2
Study type: Interventional

The study will enroll only from the first 225 subjects who were randomly assigned to treatment in G201002 (irrespective of the treatment allocation, i.e., GTx-024 or placebo) and who have completed the 12-week treatment period and 16-week durability period to assess the long-term durability of response to GTx-024 on SUI symptoms. The extension study will follow subjects for an additional 20 weeks to help better assess the durability of response in these subjects and will provide additional efficacy and safety data for the subjects. Subjects will not be provided with any study treatments and will be off-drug during this extension study.

NCT ID: NCT03508258 Withdrawn - Clinical trials for Non-valvular Atrial Fibrillation

Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF)

Start date: September 1, 2017
Phase:
Study type: Observational

Study of patients with nonvalvular atrial fibrillation (NVAF) who are newly prescribed NOACs (Novel Oral Anticoagulants) in routine clinical practice in England

NCT ID: NCT03506802 Withdrawn - Clinical trials for Recurrent Plasma Cell Myeloma

TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma

NYSCT MM
Start date: July 10, 2018
Phase: Phase 1
Study type: Interventional

This phase I trial studies the side effects of NY-ESO-1 TCR engineered peripheral blood mononuclear cells (PBMC) and peripheral blood stem cells (PBSC) after melphalan conditioning regimen in treating participants with multiple myeloma that has come back or does not respond to treatment. The melphalan conditioning chemotherapy makes room in the patient?s bone marrow for new blood cells (PBMC) and blood-forming cells (stem cells) to grow. Giving NY-ESO-1 TCR PBMC and stem cells after the conditioning chemotherapy is intended to replace the immune system with new immune cells that have been redirected to attack and kill the cancer cells and thereby improve immune system function against cancer. Giving NY-ESO-1 TCR PBMC and PBSC after melphalan may work better at treating multiple myeloma.

NCT ID: NCT03506139 Withdrawn - Glioblastoma Clinical Trials

Biologically-based Target Volumes to Treat Newly Diagnosed Glioblastoma

Start date: May 15, 2019
Phase: Phase 2
Study type: Interventional

This clinical trial increases radiation to areas of the brain considered to be at risk for cancer. The at-risk areas are identified by a biological MRI scan. The study will look at side effects of the radiation and overall survival.

NCT ID: NCT03505060 Withdrawn - HIV Infections Clinical Trials

Evaluating the Safety and Immunogenicity of the IHV01 Protein Vaccine Primed and Co-Administered With HIV DNA CON-S Env Vaccine in Healthy, HIV-1-Uninfected Adults

Start date: January 1, 2019
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the safety and immunogenicity of the IHV01 protein vaccine primed and co-administered with HIV DNA CON-S env vaccine in healthy, HIV-1-uninfected adults.

NCT ID: NCT03503279 Withdrawn - Intubation Clinical Trials

Endotracheal Tube Placement Using McGrath MAC® Video Laryngoscope Versus Macintosh Laryngoscope

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

This study aims... - To assess the difference in intubation difficulty scale (IDS) score following ETT placement using McGrath MAC® video laryngoscope versus conventional intubation with Macintosh laryngoscope for bariatric surgery patients - To assess the difference in hemodynamic stimulation (airway manipulation) events in both groups - To assess the overall difference of the duration (seconds) of ETT placement between both groups - To assess the difference of the duration (seconds) of ETT placement during every attempt (maximum of three attempts) between both groups. - To assess the difference of STOP BANG score between both groups - To assess the number of intubation attempts between both groups